These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13931194)

  • 1. Actions of two aldosterone antagonists on cat perfused kidneys.
    LOCKETT MF; ROBERTS CN
    Br J Pharmacol Chemother; 1963 Jun; 20(3):443-8. PubMed ID: 13931194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3- (16Beta,17beta-dihydroxy-3-oxoandrost-4-en-17alpha-yl) propionic acid gamma-lactone, its preparation and antimineralocorticoid activity.
    Chinn LJ; Hofmann LM
    J Med Chem; 1973 Jul; 16(7):839-43. PubMed ID: 4725930
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism between the effect of aldosterone and a synthetic steroid lactone on the renal excretion of sodium and potassium in man.
    ROSS EJ; BETHUNE JE
    Lancet; 1959 Jan; 1(7064):127-9. PubMed ID: 13621657
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of a new antialdosterone compound, prorenone.
    Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Corvol P
    Endocrinology; 1979 Apr; 104(4):1194-200. PubMed ID: 436757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
    Bianchi S; Bigazzi R; Campese VM
    Kidney Int; 2006 Dec; 70(12):2116-23. PubMed ID: 17035949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic edema and its treatment by aldosterone inhibitors. Effects of the spirolactone SC-9420].
    ROMANI JD
    Gaz Med Fr; 1961 Jun; 133():887-92. PubMed ID: 13743001
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of spironolactone in modifying the renal electrolyte effects of hydrochlorothiazide in laboratory animals.
    KAGAWA CM; DRILL VA
    Arch Int Pharmacodyn Ther; 1962 Apr; 136():283-90. PubMed ID: 14453072
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of spirolactone SC 8109 on renal function in normal human subjects.
    WIGGINS RA; HUTCHIN ME; CARBONE JV; DOOLAN PD
    Proc Soc Exp Biol Med; 1959 Mar; 100(3):625-7. PubMed ID: 13634231
    [No Abstract]   [Full Text] [Related]  

  • 9. [On aldosterone inhibitors: comparison of the actions of progesterone and spironolactone].
    HOUDAS Y; FALET R; FAVAREL-GARRIGUES JC
    J Physiol (Paris); 1963; 55():264-5. PubMed ID: 13955045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the renal effects of the spirolactone, SC 9420, in man].
    ROMANI JD; KELLER A
    Sem Hop Ther Paris; 1962 Apr; 38():332-7. PubMed ID: 14493539
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the treatment of essential hypertension.(Control of blood pressure, active blood volume, venous pressure, circulation time and mineral metabolism after Repicin and spirolactone medication)].
    SCHAEFER HE; WOELFER HJ; SCHNEIDER KW
    Munch Med Wochenschr; 1962 Feb; 104():234-9. PubMed ID: 14497940
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of heparinoid and spirolactone on the renal excretion of sodium and aldosterone.
    CEJKA V; de VRIES L; van DAATSELAAR J; BORST JG; MAJOOR CL
    Lancet; 1960 Feb; 1(7119):317-9. PubMed ID: 13808736
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
    Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
    Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine attenuates the progression of chronic renal failure.
    Shimizu MH; Coimbra TM; de Araujo M; Menezes LF; Seguro AC
    Kidney Int; 2005 Nov; 68(5):2208-17. PubMed ID: 16221220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of edema with an orally administered spirolactone.
    TUBLIN IN; BERMAN LB
    JAMA; 1960 Oct; 174():869-71. PubMed ID: 13778517
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypokalemis, hypochloremia and alkalosis in the long-term treatment of edematous heart insufficiency with benzothiadiazine diuretics. III. Effects of spirolactone].
    OLESEN K; SANDOE E
    Ugeskr Laeger; 1962 Jul; 124():1037-41. PubMed ID: 14481741
    [No Abstract]   [Full Text] [Related]  

  • 18. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Casals-Stenzel J; Buse M; Wambach G; Losert W
    Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on cation transport in cold-stored human erythrocytes. II. Effect of a steroidal antagonist of aldosterone (SC 9420) on sodium and potassium transfer.
    D'AMICO G; CESANA A
    Experientia; 1961 Mar; 17():112-3. PubMed ID: 13719153
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.